Pharmacokinetics and Pharmacodynamics of Cephalosporins in Cerebrospinal Fluid

被引:0
作者
Irja Lutsar
Ian R. Friedland
机构
[1] Pfizer Global Research & Development Ltd,Sandwich Laboratories
[2] Merck & Co. Inc.,Merck Research Laboratories
来源
Clinical Pharmacokinetics | 2000年 / 39卷
关键词
Meningitis; Cephalosporin; Ceftriaxone; Cefotaxime; Bacterial Meningitis;
D O I
暂无
中图分类号
学科分类号
摘要
Largely because of their low lipophilicity, cephalosporins poorly penetrate through the blood-brain barrier, achieving relatively low cerebrospinal fluid (CSF) concentrations. However, the minimum bactericidal concentrations (MBCs) of the extended spectrum cephalosporins for common meningeal pathogens are generally low; thus, therapeutic CSF drug concentrations several-fold greater than the MBC can be achieved with currently recommended dosage regimens. However, the effectiveness of cephalosporin therapy is unreliable in patients with meningitis caused by highly penicillin-resistant pneumococci.
引用
收藏
页码:335 / 343
页数:8
相关论文
共 50 条
  • [41] Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants
    Chen, Xing-Kai
    Shi, Hai-Yan
    Leroux, Stephanie
    Xu, Hai-Yan
    Zhou, Yue
    Zheng, Yi
    Huang, Xin
    Li, Yan
    Jacqz-Aigrain, Evelyne
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (04)
  • [42] Molecular Typing of Bacteria Directly from Cerebrospinal Fluid
    M. C. Enright
    K. Knox
    D. Griffiths
    D. W. M. Crook
    B. G. Spratt
    European Journal of Clinical Microbiology and Infectious Diseases, 2000, 19 : 627 - 630
  • [43] Population Pharmacokinetics and Dosing Regimen Optimization of Linezolid in Cerebrospinal Fluid and Plasma of Post-operative Neurosurgical Patients
    Li, SiChan
    Wang, YueFei
    Dong, Hui
    Zhu, Yuan
    Cao, Peng
    Meng, Liang
    Wang, Yang
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (03) : 884 - 892
  • [44] Plasma and cerebrospinal fluid population pharmacokinetics of vancomycin in postoperative neurosurgical patients after combined intravenous and intraventricular administration
    Li, Xingang
    Sun, Shusen
    Ling, Xi
    Chen, Kai
    Wang, Qiang
    Zhao, Zhigang
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (12) : 1599 - 1607
  • [45] Treatment of cerebrospinal fluid rhinorrhea
    DeConde, Adam S.
    Suh, Jeffrey D.
    Ramakrishnan, Vijay R.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2015, 23 (01) : 59 - 64
  • [46] Cerebrospinal Fluid Shunt Infections
    Simon, Tamara D.
    Schaffzin, Joshua K.
    Podkovik, Stacey
    Hodor, Paul
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (04) : 757 - 775
  • [47] Penetration of Colistin into Cerebrospinal Fluid
    Markantonis, S. L.
    Markou, N.
    Fousteri, M.
    Sakellaridis, N.
    Karatzas, S.
    Alamanos, I.
    Dimopoulou, E.
    Baltopoulos, G.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (11) : 4907 - 4910
  • [48] Management of cerebrospinal fluid otorrhea
    Escorihuela Garcia, Vicente
    Llopez Carratala, Ignacio
    Fernandez Julian, Enrique
    Marco Algarra, Jaime
    ACTA OTORRINOLARINGOLOGICA ESPANOLA, 2013, 64 (03): : 191 - 196
  • [49] Stability of procalcitonin in cerebrospinal fluid
    Dorresteijn, Kirsten R. I. S.
    Jellema, Korne
    Ponjee, Gabrielle A. E.
    Verheul, Rolf J.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (10) : E230 - E232
  • [50] Imaging of Cerebrospinal Fluid Leaks
    Hofmann, Erich
    Behr, Robert
    Schwager, Konrad
    CLINICAL NEURORADIOLOGY-KLINISCHE NEURORADIOLOGIE, 2009, 19 (02): : 111 - 121